Induction of apoptosis and inhibition of HL-60 cell proliferation by survivin antisense oligonucleotide
ZHU Yong-Sheng, GUO Xiang, GE Juan
Second Affiliated Hospital of Nanjing Medical University, Nanjing 210011, China. zhuysh@yahoo.com.cn
Abstract OBJECTIVE: To investigate the effects of survivn antisense oligonucleotide(ODN) on cell proliferation and apoptosis of HL-60 cells. METHODS: Synthetic ODN was completely phosphorothioate-modified. Cationic lipid-mediated antisense ODN was transferred into HL-60 cells. The expression of survivin mRNA and protein was detected by RT-PCR and Western Blot.The incorporation of MTT was used as the measurement of HL-60 proliferation. The cell-cycle and apoptosis were analyzed by flow cytometry. RESULTS: HL-60 cells spontaneously expressed survivin mRNA and protein. Both mRNA and protein expression of survivin decreased significantly in the antisense ODN transfected cells in comparison to that in the original cells and cells transfected with sense ODN.Survivin antisense ODN significantly inhibited cell proliferation and induced apoptosis in a dose-dependent manner. The cell-cycle in the antisense ODN-transfected cells stopped at the G_2/M phase. CONCLUSIONS: Antisense ODN targeting at survivin mRNA can inhibit HL-60 cell proliferation and induce G_2/M stop and apoptosis.
Key words ：
Survivin
Antisense oligonucleotide
Apoptosis
Leukemia
Cite this article:
ZHU Yong-Sheng,GUO Xiang,GE Juan. Induction of apoptosis and inhibition of HL-60 cell proliferation by survivin antisense oligonucleotide[J]. 中国当代儿科杂志, 2006, 8(2): 97-100.
ZHU Yong-Sheng,GUO Xiang,GE Juan. Induction of apoptosis and inhibition of HL-60 cell proliferation by survivin antisense oligonucleotide[J]. CJCP, 2006, 8(2): 97-100.
URL:
http://www.zgddek.com/EN/ OR http://www.zgddek.com/EN/Y2006/V8/I2/97
[1]
WU Yuan-Yuan, CAI Sheng-Yang, HUANG Wei, LI Si-Si, LI Wei, DONG Ao. Clinical and laboratory characteristics of juvenile myelomonocytic leukemia
[2]
CHENG Yan-Qin, ZHAI Xiao-Wen. Clinical application of minimal residual disease detection in childhood acute leukemia
[3]
ZHANG Wan-Yan, ZHANG Yuan, DONG Nan-Nan, WANG Ying-Chao, SHENG Guang-Yao, XU Xue-Ju, LIU Yu-Feng. Clinical features and prognosis of malignancy-associated hemophagocytic lymphohistiocytosis in children: a clinical analysis of 24 cases
[4]
CHEN Xiao-Xiao, SHEN Shu-Hong. Research advances in pharmacogenomics of mercaptopurine
[5]
XU Jin-Yun, LUO Jian-Ming. Association between BIM gene and glucocorticoid resistance in children with acute lymphoblastic leukemia
[6]
FU Xiao-Yan, XIE Xiao-Tian, ZHAO Yan. Neurocognitive function of children with acute lymphoblastic leukemia and long-term disease-free survival and related influencing factors
[7]
WANG Ni-Na, YE Qi-Dong. Advances in targeted therapy for childhood acute myeloid leukemia
[8]
WU Jun, LU Ai-Dong, ZHANG Le-Ping. Clinical characteristics and prognostic analysis of children and adolescents over 10 years of age with acute lymphoblastic leukemia
[9]
KONG Qing-Lin, AN Xi-Zhou, GUAN Xian-Min, MA Yi-Mei, LI Peng-Fei, LIANG Shao-Yan, HU Yan-Ni, CUI Ying-Hui, YU Jie. Expression of β-integrin family members in children with T-cell acute lymphoblastic leukemia
[10]
LI De-Yuan, WU Jin-Lin, LUO Li-Li, QIAO Li-Na, LIU Zhong-Qiang, LU Guo-Yan, WANG Yang. Role of c-Jun N-terminal kinase-mediated FOXO3a nuclear translocation in neuronal apoptosis in neonatal rats with hypoxic-ischemic brain damage
[11]
MIAO Hong-Jun, WANG Dan, GE Xu-Hua, LI Xiao-Nan. Effects of ω-3 polyunsaturated fatty acids on lymphocyte apoptosis rate in rats with sepsis
[12]
CHEN Zai-Sheng, ZHENG Ling, CHEN Yi-Qiao, YANG Jing-Hui, LI Jian. Pathogens of infections in the induction period of childhood acute lymphoblastic leukemia and drug resistance of isolated strains
[13]
MENG Jun-Jie, LI Shi-Ping, ZHAO Feng-Yan, TONG Yu, MU De-Zhi, QU Yi. Effect of telomerase activation on biological behaviors of neural stem cells in rats with hypoxic-ischemic insults
[14]
ZHANG Pei-Fen, FENG Xiao-Qin, WU Cui-Ling, ZHANG Yu-Ming. Clinical features of children with acute lymphoblastic leukemia complicated by pulmonary infection after chemotherapy
[15]
NI Ya-Ru, XU Xiao-Jun, TANG Yong-Min. Progress in clinical studies of chimeric antigen receptor engineered T cells for treatment of childhood cancer
